Kristen Ambrose, Senior Vice President and Chief Accounting Officer at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a $116 billion market cap biotechnology company with strong financial health according ...

Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

Antiretroviral Agents under drug class are estimated to grow at a CAGR of 6.4% creating an absolute $ opportunity of US$ 6.0 billion between 2024 and 2034 North America and East Asia are expected ...

Most neurons that carry signals regarding movement and higher-level functions, such as thinking and reading, are myelinated. Neurons that control feelings of pain and temperature are sometimes ...

Anyone who has ever tried to purchase or sell a home will be familiar with the significance of a property's fair market value (FMV). FMV is the price that a property would sell for on the open ...

Consider the “absolute value” function, which looks like this: On the left side of this V-shaped curve, tangent lines slope downward. On the right side, they slope upward. At the bottom vertex, the ...

The future will be shaped by those who can integrate advanced technologies to automate key processes, and deliver value-added services ... For years these functions have operated in silos ...

What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.